Biotricity Inc.
OTC
Closed
Jul 17, 2026
Day's Range
0.106052 wk Range
0.0879Key Statistics
Symbol
BTCY
Name
Biotricity Inc.
Currency
USD
Exchange
OTC
High
0.11280000
Low
0.10600000
Open
‪0.1060‬
Last
‪0.1128‬
Market Cap
2.28M
Pe Ratio
‪-0.98‬
Volume
10.51K
Average Volume
41.22K
Dividend Yield
‪0.00%‬
Change
-0.00020
Percent Change
-0.18
Timestamp
2026-07-17
Close
0.11280000
Today Range Start
‪0.1060‬
Today Range End
‪0.1128‬
52 Week Range Start
‪0.0879‬
52 Week Range End
‪0.7536‬
Type
Stocks
Country
United States
Compliance - BTCY - Biotricity Inc.
Compliance
Status
COMPLIANT
Report Date
2025-02-20
Business Screen
COMPLIANT
Financial Screen
COMPLIANT
Compliant Revenue
‪98.00%‬
Non Compliant Revenue
‪2.00%‬
Questionable Revenue
‪0.00%‬
Securities To Market Cap Ratio
‪10.00%‬
Debt To Market Cap Ratio
‪10.00%‬
Historical Data - BTCY - Biotricity Inc.
Historical Data
Market Cap - BTCY - Biotricity Inc.
Market Cap
2026-07-17
2.28M
2026-07-15
3.43M
2026-07-14
2.98M
2026-07-13
3.43M
2026-07-09
3.34M
2026-07-08
3.40M
2026-07-07
3.57M
2026-07-06
3.57M
2026-07-01
3.66M
2026-06-30
4M
Splits - BTCY - Biotricity Inc.
Splits
2023-07-03
1-for-6 split (6)
Earnings - BTCY - Biotricity Inc.
Earnings
Balance Sheet - BTCY - Biotricity Inc.
Balance Sheet
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
 Assets | 6.44M | 5.64M | 5.94M | 6.51M | 16.67M | 4.43M |
| Liabilities | 39.40M | 35.65M | 35.91M | 26.35M | 18.82M | 11.27M |
| Shareholders Equity | -32.96M | -30.01M | -29.97M | -19.84M | -2.14M | -6.83M |
Cash Flow - BTCY - Biotricity Inc.
Cash Flow
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Operating Activities | - | - | - | - | - | - |
| Investing Activities | - | - | - | - | - | - |
| Financing Activities | - | - | - | - | - | - |
| End Cash Position | 149.78K | 365.14K | 786.06K | 570.46K | 12.06M | 2.20M |
| Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid | 2.87M | 3.61M | 2.02M | 1.62M | 553.26K | 204.16K |
| Free Cash Flow | -718.95K | -2.38M | -6.69M | -13.54M | -15.19M | -11.08M |
Income Statement - BTCY - Biotricity Inc.
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 15.99M | 13.79M | 12.06M | 9.63M | 7.65M | 3.38M |
| Cost of Goods | 3.04M | 3.22M | 3.70M | 4.19M | 3.08M | 2.11M |
| Gross Profit | 12.94M | 10.56M | 8.35M | 5.44M | 4.57M | 1.27M |
| Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.69M | -2.44M | -8.82M | -15.40M | -16.73M | -13.35M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 12.47K | -770.35K | -74.29K | -665.81K | -1.82M | 341.77K |
| Pre Tax Income | -2.40M | -8.42M | -14.09M | -18.65M | -29.13M | -15.49M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -2.40M | -8.42M | -14.09M | -18.65M | -29.13M | -15.49M |
| EPS Basic | -0.115 | -0.555 | -1.66 | -2.256 | -3.99 | -2.628 |
| EPS Diluted | -0.115 | -0.555 | -1.66 | -2.256 | -3.99 | -2.628 |
| Basic Shares Outstanding | 27.30M | 21.52M | 8.99M | 8.65M | 7.57M | 6.25M |
| Diluted Shares Outstanding | 27.30M | 21.52M | 8.99M | 8.65M | 7.57M | 6.25M |
| Ebit | 1.70M | -3.21M | -8.90M | -16.07M | -18.56M | -13.01M |
| Ebitda | 1.87M | -2.65M | -8.90M | -15.58M | -17.87M | -13.41M |
| Net Income Continuous Operations | -2.40M | -8.42M | -14.09M | -18.65M | -29.13M | -15.49M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 3.05M | - | - | - | - |
Recommendations - BTCY - Biotricity Inc.
Recommendations
Profile - BTCY - Biotricity Inc.
Profile
Mic Code
PINX
Sector
Healthcare
Industry
Medical Devices
Employees
46
Biotricity Inc. is a cutting-edge health technology company focused on developing and commercializing biometric remote monitoring solutions aimed at preventive healthcare. The company is renowned for its flagship medical devices that cater primarily to the cardiac health sector. These innovations are designed to assist healthcare professionals in monitoring patients' heart health in real-time, thereby enhancing clinical decision-making and improving patient outcomes. Biotricity's advanced remote monitoring technology bridges the gap between healthcare and lifestyle management, facilitating continuous, accurate biometric data acquisition. Operating predominantly in the cardiology and chronic disease sectors, Biotricity's products empower proactive healthcare through its comprehensive, cloud-based platform that integrates seamlessly with clinical workflows. In the financial market, Biotricity Inc. represents a significant player in the intersection of health technology and innovative medical solutions, underlining the growing importance of telemedicine and health informatics in modern healthcare systems. Headquartered in California, Biotricity is part of a dynamic industry continuously evolving to meet the demands of advanced, technology-driven healthcare delivery.
Profile Details
Type
Common Stock
Ceo
Dr. Waqaas Al-Siddiq Ph.D.
Address
203 Redwood Shores Parkway
City
Redwood City
State
CA
Zip
94065
Country
United States
Phone
800 590 4155
